Cancer Centers of Southwest Oklahoma Research
Lawton, Oklahoma, United States
Cancer treatment center in Comanche County, Oklahoma
104 NW 31st St, Lawton, OK 73505
About Cancer Centers of Southwest Oklahoma Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
81
SWOG Cancer Research Network
25
Alliance for Clinical Trials in Oncology
15
ECOG-ACRIN Cancer Research Group
7
SCRI Development Innovations, LLC
6
NRG Oncology
3
Alliance Foundation Trials, LLC.
2
Celgene
2
NSABP Foundation Inc
2
Academic and Community Cancer Research United
1
Agendia
1
Clinical Trials at Cancer Centers of Southwest Oklahoma Research
During the past decade, Cancer Centers of Southwest Oklahoma Research conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 50 clinical trials were completed, i.e. on
average, 54.3% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 28 clinical trials were completed. i.e. 96.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
2006-02-01
2011-03-01
Terminated
208
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
2007-07-01
2013-02-21
Completed
280
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Centers of Southwest Oklahoma Research" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "SWOG Cancer Research Network" with 25 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "SCRI Development Innovations, LLC"
with 7 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Centers of Southwest Oklahoma Research"
#1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 42 different institutions and companies that were
collaborators in the rest 40 trials.
Clinical Trials Conditions at Cancer Centers of Southwest Oklahoma Research
According to Clinical.Site data, the most researched conditions in "Cancer Centers of Southwest Oklahoma Research" are
"Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Cancer Centers of Southwest Oklahoma Research" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Centers of Southwest Oklahoma Research
Most popular intervention types in "Cancer Centers of Southwest Oklahoma Research" are "Drug" (127 trials), "Other" (93 trials), "Biological" (70 trials), "Procedure" (41 trials) and "Radiation" (24 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (40 trials), "Computed Tomography" (28 trials), "Biospecimen Collection" (25 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Centers of Southwest Oklahoma Research
The vast majority of trials in "Cancer Centers of Southwest Oklahoma Research" are
128 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Cancer Centers of Southwest Oklahoma Research
Currently, there are NaN active trials in "Cancer Centers of Southwest Oklahoma Research".
undefined are not yet recruiting,
46 are recruiting,
67 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in Cancer Centers of Southwest Oklahoma Research,
4 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Centers of Southwest Oklahoma Research, 4 "Phase 1"
clinical trials were conducted, 76 "Phase 2" clinical
trials and 84 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".